Advertisement
Screener

CUBIST PHARMACEUTICALS INC Stock-Based Compensation

CUBIST PHARMACEUTICALS INC Stock-Based Compensation

CUBIST PHARMACEUTICALS INC reported Stock-Based Compensation of $28.37 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-07.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2014-11-07

  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2014-09-30 was $9.40M, a 18.07% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2014-06-30 was $10.13M, a 20.42% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2014-03-31 was $8.84M, a 14.39% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-12-31 was $8.25M, a 27.79% increase year-over-year.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2013 was $32.36M, a 25.89% increase from fiscal 2012.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $25.70M, a 32.70% increase from fiscal 2011.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $19.37M, a 21.17% increase from fiscal 2010.
  • CUBIST PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $15.98M, a 10.71% increase from fiscal 2009.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2014-09-30$9.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$19.53M
derived: sum of 2 quarters · filed 2014-11-07
$28.37M
10-Q · filed 2014-11-07
$36.63M
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30$10.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$18.97M
10-Q · filed 2014-08-11
$27.22M
derived: sum of 3 quarters · filed 2014-08-11
$35.19M
derived: sum of 4 quarters · filed 2014-11-07
2014-03-31$8.84M
10-Q · filed 2014-05-02
$17.09M
derived: sum of 2 quarters · filed 2014-05-02
$25.06M
derived: sum of 3 quarters · filed 2014-11-07
$33.47M
derived: sum of 4 quarters · filed 2014-11-07
2013-12-31$8.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$16.22M
derived: sum of 2 quarters · filed 2014-11-07
$24.63M
derived: sum of 3 quarters · filed 2014-11-07
$32.36M
10-K · filed 2014-02-25
2013-09-30$7.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$16.38M
derived: sum of 2 quarters · filed 2014-11-07
$24.10M
10-Q · filed 2014-11-07
$30.56M
derived: sum of 4 quarters · filed 2014-11-07
2013-06-30$8.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$16.14M
10-Q · filed 2014-08-11
$22.60M
derived: sum of 3 quarters · filed 2014-08-11
$29.35M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$7.73M
10-Q · filed 2014-05-02
$14.19M
derived: sum of 2 quarters · filed 2014-05-02
$20.94M
derived: sum of 3 quarters · filed 2014-05-02
$27.66M
derived: sum of 4 quarters · filed 2014-05-02
2012-12-31$6.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$13.21M
derived: sum of 2 quarters · filed 2014-02-25
$19.93M
derived: sum of 3 quarters · filed 2014-02-25
$25.70M
10-K · filed 2014-02-25
2012-09-30$6.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$13.48M
derived: sum of 2 quarters · filed 2013-11-12
$19.24M
10-Q · filed 2013-11-12
$24.64M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$6.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$12.49M
10-Q · filed 2013-08-06
$17.89M
derived: sum of 3 quarters · filed 2014-02-25
$23.37M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31$5.77M
10-Q · filed 2013-05-07
$11.16M
derived: sum of 2 quarters · filed 2014-02-25
$16.64M
derived: sum of 3 quarters · filed 2014-02-25
$21.27M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$5.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$10.87M
derived: sum of 2 quarters · filed 2014-02-25
$15.50M
derived: sum of 3 quarters · filed 2014-02-25
$19.37M
10-K · filed 2014-02-25
2011-09-30$5.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
$10.11M
derived: sum of 2 quarters · filed 2012-11-05
$13.97M
10-Q · filed 2012-11-05
$18.02M
derived: sum of 4 quarters · filed 2013-02-27
2011-06-30$4.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$8.49M
10-Q · filed 2012-08-07
$12.54M
derived: sum of 3 quarters · filed 2013-02-27
$16.57M
derived: sum of 4 quarters · filed 2013-02-27
2011-03-31$3.87M
10-Q · filed 2012-05-01
$7.91M
derived: sum of 2 quarters · filed 2013-02-27
$11.94M
derived: sum of 3 quarters · filed 2013-02-27
$16.07M
derived: sum of 4 quarters · filed 2013-02-27
2010-12-31$4.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27
$8.07M
derived: sum of 2 quarters · filed 2013-02-27
$12.21M
derived: sum of 3 quarters · filed 2013-02-27
$15.98M
10-K · filed 2013-02-27
2010-09-30$4.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
$8.16M
derived: sum of 2 quarters · filed 2011-11-02
$11.94M
10-Q · filed 2011-11-02
$16.18M
derived: sum of 4 quarters · filed 2012-02-27
2010-06-30$4.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29
$7.91M
10-Q · filed 2011-07-29
$12.15M
derived: sum of 3 quarters · filed 2012-02-27
$15.86M
derived: sum of 4 quarters · filed 2012-02-27
2010-03-31$3.77M
10-Q · filed 2011-04-29
$8.02M
derived: sum of 2 quarters · filed 2012-02-27
$11.73M
derived: sum of 3 quarters · filed 2012-02-27
2009-12-31$4.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27
$7.95M
derived: sum of 2 quarters · filed 2012-02-27
$14.44M
10-K · filed 2012-02-27
2009-09-30$3.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29
$10.19M
10-Q · filed 2010-10-29
2009-06-30$6.49M
10-Q · filed 2010-07-30
2008-12-31$11.83M
10-K · filed 2011-02-23